New drug VVZ-2471 put to the test in healthy adults

NCT ID NCT07531316

First seen Apr 20, 2026 · Last updated Jun 14, 2026 · Updated 10 times

Summary

This early-stage study tests whether an experimental drug called VVZ-2471 is safe and tolerable in healthy adults. About 60 people aged 18 to 65 who show high impulsivity will receive either the drug or a placebo. The results will help design future studies for people who use substances.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY CONTROLS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • VCU Institute for Drug and Alcohol Studies

    Richmond, Virginia, 23219, United States

Conditions

Explore the condition pages connected to this study.